Dr. Kristin Minkowski, MD

Dr. Minkowski practices at Houston Eye Surgery Center in Houston, Texas.

Dr. Minkowski's NPI, 1497109474, was assigned on April 15, 2016. Dr. Minkowski graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2016. Dr. Minkowski holds Texas license T1780.

Dr. Minkowski's primary practice is Houston Eye Surgery Center, at 2855 Gramercy St, Houston, TX 77025 in Harris County. The practice phone is (832) 553-7171.

Dr. Minkowski's primary practice is Houston Eye Surgery Center in Houston, Texas. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Minkowski to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Minkowski practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Minkowski's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Minkowski is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Minkowski's licenses on file in 3 states: Texas, Florida and Illinois.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Minkowski treats.

CMS data shows 2,410 Medicare services from Dr. Minkowski across 18 procedure codes in 2024, for 556 Medicare patients. Medicare paid $210,074 for them.

CMS counts 556 Medicare patients who saw Dr. Minkowski in 2024. The largest group is 75 to 84, with 241 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Minkowski's median patient age at 73, with 56% women.

In 2024, Dr. Minkowski wrote 5,761 Medicare Part D claims for 931 patients. 57% of them were for generic drugs. CMS names the drug for 5,660 of them, across 29 drugs with 11 or more claims each, at $673,692 in total drug cost. In 2023, CMS named 3,948 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Minkowski for performance year 2024, reported as part of a group. Dr. Minkowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 109 procedures of cataract surgery by Dr. Minkowski, more than 75% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Minkowski in 2023. Dr. Minkowski's most frequent co-authors are David S. Greenfield, MD, Byron L. Lam, MD and Shahnaz Miri, MD.

CMS Open Payments shows 143 general payments to Dr. Minkowski from 29 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,461.

Dr. Minkowski graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2016.

Dr. Minkowski is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 13. Check the plan with the practice before a visit.